Table 7. Resveratrol–siRNA Co-delivery Platforms in Cancer Therapy.
| nanovehicle | cancer type | cell line | target gene | size (nm) | zeta potential (mV) | encapsulation efficiency (EE) (%) | remarks | ref |
|---|---|---|---|---|---|---|---|---|
| electrospun fiber | leukemia | K562 cells | BCR-ABL | 76.9–88.3 | effective delivery of Res and siRNA, and reducing proliferation and viability of cancer cells | (370) | ||
| electrospun fiberLiposome | leukemia | K562 cells | BCR-ABL | 117.2 | –11 | 85.9 | releasing Res in a prolonged-release behavior, knock-down of BCR-ABL gene and decreasing viability and proliferation of cancer cells | (371) |